Health

Abivax Drug Trial Results Mixed

Updated 2026-06-01 21:35 UTC 1 source Negative

Abivax's experimental ulcerative colitis drug showed strong efficacy in a trial, but raised safety concerns that led to a drop in company shares.

Coverage timeline — 1 article

STAT News

STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns

Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but shares of the company tanked on safety concerns.

2026-06-01 21:31 UTC